SEED, NIH's Seed Fund, with Director Dr. Matt McMahon, at 18th Non-Dilutive Funding Summit (2023) скачать в хорошем качестве

SEED, NIH's Seed Fund, with Director Dr. Matt McMahon, at 18th Non-Dilutive Funding Summit (2023)

WHAT IS SEED? Small Business Education and Entrepreneurial Development (SEED) accelerates the conversion of scientific discoveries into healthcare solutions. SEED identifies and scales approaches that enable researchers at small businesses, in academic, and elsewhere to convert scientific discoveries into impactful healthcare solutions. SEED also coordinates early-stage product development activities across the National Institutes of Health (NIH) and collaborates with universities and research institutions, small businesses, trade associations and societies, angel investors, venture capitalists, and strategic partners. SEED educates and assists NIH-funded innovators as they transition from discovery science to product development. SEED helps academic innovators validate the potential health impacts of their discoveries through a national network of proof-of-concept centers and provides a host of professional advisory services to small business innovators funded by NIH’s $1.2 billion/year SBIR and STTR programs. DR. McMAHON Dr. Matthew McMahon leads the Small Business Education and Entrepreneurial Development Office (SEED) helping to transform cutting-edge technologies into products that improve health and save lives. He has a diverse background in academia, small business, congressional policy, and NIH program management. He previously served as the first director of the National Heart, Lung, and Blood Institute’s Office of Translational Alliances and Coordination, and he created and led the National Eye Institute’s Office of Translational Research. His previous experience also includes service as the principal scientist for the bionic eye company Second Sight Medical Products and as a staff member on both the United States Senate and House of Representatives committees responsible for science, technology, and innovation policy. Dr. McMahon holds a B.S. in Optical Engineering from the University of Rochester and an M.A. and Ph.D. in Experimental Psychology from the University of California, San Diego. FREEMIND Founded in 1999, the FreeMind Group helps life science companies secure non-dilutive funding to fund R&D. Every year FreeMind garners over $100 million for its clients, with awards ranging from hundred-thousand dollar grants to multi-million dollar programs. Funding sources include NIH, DOD, BARDA, NSF, FDA, etc., as well as private foundations. Learn more here: https://freemindgroup.com/about-us/. You may find our LinkedIn page useful, as we regularly post news about non-dilutive funding opportunities, announcements about conferences with the best partnering for life science professionals, and discounts for those conferences. Connect with us here:   / freemind-group  . We hope you gain useful information from these recordings of the 18th Non-Dilutive Funding Summit.